Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00629343 · BASELINE

Baseline characteristics

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide · Source last updated 2025-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      3
    2. group Id
      BG001
      value
      3
    3. group Id
      BG002
      value
      17
    4. group Id
      BG003
      value
      23
    units
    Participants
groups
  1. description
    Cohort 1: Participants received 25 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG000
    title
    Azacitidine 25 mg
  2. description
    Cohort 2: Participants received 50 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG001
    title
    Azacitidine 50 mg
  3. description
    Cohort 3: Participants received 75 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG002
    title
    Azacitidine 75 mg
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          23
      title
      ≥ 18 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
      title
      Female
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
      title
      Male
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          23
      title
      Unknown
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex/Gender, Customized
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      3
    2. group Id
      BG001
      value
      3
    3. group Id
      BG002
      value
      17
    4. group Id
      BG003
      value
      23
    units
    Participants
groups
  1. description
    Cohort 1: Participants received 25 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG000
    title
    Azacitidine 25 mg
  2. description
    Cohort 2: Participants received 50 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG001
    title
    Azacitidine 50 mg
  3. description
    Cohort 3: Participants received 75 mg Azacitidine sub-cutaneously, and 200 mg/m\^2 Temozolomide orally; both once a day on Days 1 - 5 of a 28-day cycle.
    id
    BG002
    title
    Azacitidine 75 mg
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          23
      title
      ≥ 18 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
      title
      Female
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
      title
      Male
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          23
      title
      Unknown
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex/Gender, Customized
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice